A new microarray, enriched in pancreas and pancreatic cancer cdnas to identify genes relevant to pancreatic cancer

Cancer Genomics and Proteomics

Volumn 1, Issue 5-6, 2004, Pages 371-386

  Poguegeile, Kay L ^a   MacKey, Julie A ^a   George, Ryan D ^a   Wood, Paul G ^b   Lee, Kenneth K W ^c   Moser, A James ^c   Tillman, Derrick L ^d   Lyons Weiler, James ^d   Whitcomb, David C ^a,e  

^a Division of Gastroenterology Hepatology and Nutrition   (United States)

^b W944 Biomedical Science Tower North   (United States)

^c 497 Scaife Hall ^*  (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Differential gene expression; Microarray; Pancreatic cancer

Indexed keywords

EID: 33749257710     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Ahmedin J, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ: Cancer statistics. CA Cancer J Clin 53: 5-26, 2003.
2. Warshaw AL and Fernandez-del Castillo C: Pancreatic carcinoma. N Engl J Med 326: 455-465, 1992.
3. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871): 530-536, 2002.
4. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO and Staudt LM: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769): 503-511, 2000.
5. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P and Borresen-Dale AL:Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. PNAS USA 98(19): 10869-10874, 2001.
6. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D: Molecular portraits of human breast tumours. Nature 406(6797): 747-52, 2000.
7. Kim SK, Lund J, Kiraly M, Duke K, Jiang M, Stuart JM, Eizinger A, Wylie BN and Davidson GS: A gene expression map for Caenorhabditis elegans. Science 293(5537): 2087-2092, 2001.
8. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C and Meltzer PS: Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nature Med 7(6): 673-9, 2001.
9. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, Gangeswaran R, Jones M, Terris B, Costello E, Neoptolemos JP and Lemoine NR: Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Path 201(1): 63-74, 2003.
10. Friess H, Ding J, Kleeff J, Fenkell L, Rosinski JA, Guweidhi A, Reidhaar-Olson JF, Korc M, Hammer J and Buchler MW: Microarray-based identification of differentially expressed growth-and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci 60(6): 1180-1199, 2003.
11. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB and Von Hoff DD: Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 62(10): 2890-2896, 2002.
12. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M and Hruban RH: Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Path 160(4): 1239-1249, 2002.
13. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO and Goggins M: Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Path 162(4): 1151-1162, 2003.
14. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, T, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M and Hruban RH: Highly expressed genes in pancreatic ductial adenocarcinomas: A comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 63: 8614-8622, 2003.
15. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE and Hanash S: Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63(10): 2649-2657, 2003.
16. Tan ZJ, Hu XG, Cao GS and Tang Y: Analysis of gene expression profile of pancreatic carcinoma using cDNA microarray. World J Gastro 9(4): 818-823, 2003.
17. Terris B, Blaveri E, Crnogorac-Jurcevic T, Jones M, Missiaglia E, Ruszniewski P, Sauvanet A and Lemoine NR: Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Path 160(5): 1745-1754, 2002.
18. Yu XJ, Long J, Fu DL, Zhang QH and Ni QX: Analysis of gene expression profiles in pancreatic carcinoma by using cDNA microarray. Hepatobiliary Pancreat Dis Int 2(3): 467-470, 2003.
19. Patel S and Lyons-Weiler J: caGEDA: a web application for the integrated analysis of global gene expression patterns in cancer. Applied Bioinformatics 3(1): 49-62, 2004.
20. Lyons-Weiler J, Patel S and Bhattacharya S: A classificationbased machine learning approach for the analysis of genomewide expression data. Genome Res 13(3): 503-12, 2003.
21. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M Goodman SN, Sohn TA, Hruban RH, Yeo CJ and Kern SE: Tumor suppressive pathways in pancreatic carcinoma. Cancer Res 57: 1731-1734, 1997.
22. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG and Moses HL: TGFbeta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303(5659): 848-8551, 2004.
23. Li S, Becich MJ and Gilbertson J: Microarray Data Mining Using Gene Ontology. In: Medinfo M, Fieschi et al: (eds) 778-782, 2004.
24. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A and Aaltonen LA: A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391: 184-187, 1998.
25. Nony P, Gaude H, Rossel M, Fournier L, Rouault JP and Billaud M: Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/CDC37. Oncogene 22(57): 9165-175, 2003.
26. Caldas C, Hahn SA, Da Costa L, Redston MS, Schutte M, Seymour AB, Weissman CL, Hruban RH, Yeo CJ and Kern SE: Frequent somatic mutations and homozygous deletion of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet 8: 27-32, 1994.
27. Lange BM, Rebollo E, Herold A and Gonzalez C: CDC37 is essential for chromosome segregation and cytokinesis in higher eukaryotes. EMBO J 21(20): 5364-5374, 2002.
28. Doxsey SJ, Stein P, Evans L, Calarco PD and Kirschner M: Pericentrin, a highly conserved centrosome protein involved in microtubule organization. Cell 76(4): 639-650, 1994.
29. Smolikov S and Mazor Y: Krauskopf AELG1, a regulator of genome stability, has a role in telomere length regulation and in silencing. PNAS 101(6): 1656-61, 2004.
30. Rubin CI, French DL and Atweh GF: Stathmin expression and megakaryocyte differentiation: a potential role in polyploidy. Exp Hematol 31(5): 389-97, 2003.
31. Fu L and Lee CC: The circadian clock: pacemaker and tumour suppressor. Nature Reviews Cancer 3(5): 350-361, 2003.
32. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F and Okamura H:Control mechanism of the circadian clock for timing of cell division in vivo. Science 302: 255-259, 2003.
33. Kawamoto T, Noshiro M, Sato F, Maemura K, Takeda N, Nagai R, Iwata T, Fujimoto K, Furukawa M, Miyazaki K, Honma S, Honma K and Kato Y: A novel autofeedback loop of Dec1 transcription involved in circadian rhythm regulation. Biochem Biophys Res Commun 313(1): 117-124, 2004.
34. Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, Kato Y and Honma K: Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 419(6909): 841-844, 2002.
35. Zhang Li Y, H, Xie M, Hu M, Ge S, Yang D, Wan Y and Yan B: Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem J 367(Pt 2): 413-422, 2002.
36. Nishiwaki T, Daigo Y and Kawasoe T: Nakamura Y:Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromos Cancer 27(2): 169-176, 2000.
37. Wykoff CC, Pugh CW, Maxwell PH, Harris AL and Ratcliffe PJ: Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 19(54): 6297-6305, 2000.
38. Omori Y, Imai J, Suzuki Y, Watanabe S, Tanigami A and Sugano S: OASIS is a transcriptional activator of CREB/ATF family with a transmembrane domain. Biochem Biophys Res Commun 293(1): 470-7, 2002.
39. Belcredito S, Vegeto E, Brusadelli A, Ghisletti S, Mussi P, Ciana P and Maggi A: Estrogen neuroprotection: the involvement of the Bcl-2 binding protein BNIP2. Brain Res Rev 37(1-3): 335-42, 2001.
40. Cavallini G, Bovo P, Bianchini E, Carsana A, Costanzo C, Merola M, Sgarbi D, Frulloni L, Di Francesco V, Libonati M and Palmieri M: Lithostathine messenger RNA expression in different types of chronic pancreatitis. Mol Cell Bioch 185(1-2): 147-52, 1998.
41. Schedin PJ, Eckel-Mahan KL, McDaniel SM, Prescott JD, Brodsky KS, Tentler JJ and Gutierrez-Hartmann A: ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells: Oncogene 23(9): 1766-1779, 2004.
42. Asada S, Choi Y, Yamada M, Wang SC, Hung MC, Qin J and Uesugi M: External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator. PNAS USA 99(20): 12747-12752, 2002.
43. Neve RM, Ylstra B, Chang CH, Albertson DG and Benz CC: ErbB2 activation of ESX gene expression. Oncogene 21(24): 3934-3938, 2002.
44. Yen TWF, Aardal NP, Bronner MP, Thorning DR, Savard CE, Lee SP and Bell RH Jr: Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery Volume 131(2): 129-134, 2002.
45. Jaskiewicz K, Nalecz A, Rzepko R and Sledzinski Z: Immunocytes and activated stellate cells in pancreatic fibrogenesis. Pancreas 26(3): 239-242, 2003.
46. Cavestro GM, Frulloni L, Nouvenne A, Neri TM, Calore B, Ferri B, Bovo P, Okolicsanyi L, Di Mario F and Cavallini G: Association of keratin 8 gene mutation with chronic pancreatitis. Digest Liver Dis 35(6): 416-420, 2003.
47. Casanova ML, Bravo A, Ramirez A, Morreale de Escobar G, Were F, Merlino G, Vidal M and Jorcano JL: Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8. J Clin Inves 103(11): 1587-1595, 1999.
48. Scupoli MT, Sartoris S, Tosi G, Ennas MG, Nicolis M, Cestari T, Zamboni G, Martignoni G, Lemoine NR, Scarpa A and Accolla RS: Expression of MHC class I and class II antigens in pancreatic adenocarcinomas. Tissue Antigens 48(4 Pt 1): 301-311, 1996.
49. Pendaries C, Tronchere H, Plantavid M and Payrastre B: Phosphoinositide signaling disorders in human diseases. FEBS Lett 546(1): 25-31, 2003.
50. Lee CS, Buttitta LA, May NR, Kispert A and Fan CM: SHH-N upregulates Sfrp2 to mediate its competitive interaction with WNT1 and WNT4 in the somitic mesoderm. Development 127: 109-118, 2000.
51. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL and Hebrok M: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Comm Nature 425(6960): 851-856, 2003.
52. Brophy PD, Lang KM and Dressler GR: The secreted frizzled related protein 2 (SFRP2) gene is a target of the Pax 2 transcription factor. J Biol Chem 278(52): 52401-52405, 2003.
53. Stoica GE, Kuo A, Powers C, Bowden ET, Sale EB, Riegel AT and Wellstein A: Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J Bio Chem 277(39): 35990-35598, 2002.
54. Sumi Y, Muramatsu H, Takei Y, Hata K, Ueda M and Muramatsu T: Midkine, a heparin-binding growth factor, promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model. J Cell Sci 115(Pt 13): 2659-2667, 2002.
55. Shimada H, Nabeya Y, Tagawa M, Okazumi S, Matsubara H, Kadomatsu K, Muramatsu T, Ikematsu S, Sakuma S and Ochiai T: Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma. Cancer Sci 94(7): 628-32, 2003.
56. Sato N, Fukushima N, Maitra A, Iacobuzio-Donahue CA, van Heek NT, Cameron JL, Yeo CJ, Hruban RH and Goggins M: Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Path 164(3): 903-14, 2004.